Wilson Sonsini is proud to sponsor LaunchBio's Invest in Cures, Impact Investing Through Disease Foundations.

Join us on February 20 at the University of California, San Diego (UCSD), home to the Gene Therapy Initiative, to explore the transformative potential of impact investing in addressing rare disease challenges. This forum highlights the promise of venture philanthropy and innovative collaborations, offering hope for the commercialization of therapies that could revolutionize rare disease treatment. Learn from venture leaders, advocates, researchers, and entrepreneurs as they share insights on accelerating translational research and advancing cures for patients through strategic funding and collaboration. 

Partner Laurie McNamara will moderate the panel session, Moving from Lab to Marketplace—Successes and Challenges of a Rare Disease Biotech Startup, with fellow panelists Mike Krenn, CEO of TL Foundation / Connect, Carter Cliff, CEO of Papillon Therapeutics, Stephanie Cherqui, PhD, Professor. of Pediatrics, at UCSD, and. Devora Rossi, Senior Innovation & Commercialization Manager at UCSD, Office of Innovation & Commercialization.

Invest in Cures features main-stage sessions, panel discussions, intimate gatherings and high-level networking opportunities. This unique event brings together researchers, clinicians and investment professionals from leading foundations to discuss cutting-edge approaches to supporting and funding breakthrough therapies.

Join us to connect and collaborate with leaders shaping the future of rare disease therapies.